Lila Ramaiah

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Systematic Review

Coronavirus Disease

Protein Protein

Top Venues

The AAPS journal

This page only lists publications with an associated author ORCID identifier.

Publications

Jacob Felderman, Lila Ramaiah, Maria-Dolores Vazquez-Abad, Dean Messing, Ying Chen
Anti-Drug Antibody Incidence Comparison of Therapeutic Proteins Administered Via Subcutaneous vs. Intravenous Route. The AAPS journal 26 (3) (2024)
Jacob Felderman, Lila Ramaiah, Maria-Dolores Vazquez-Abad, Dean Messing, Ying Chen
Anti-Drug Antibody Incidence Comparison of Therapeutic Proteins Administered Via Subcutaneous vs. Intravenous Route. The AAPS journal 26 (3) (2024)
Jacob Felderman, Lila Ramaiah, Maria-Dolores Vazquez-Abad, Dean Messing, Ying Chen
Anti-Drug Antibody Incidence Comparison of Therapeutic Proteins Administered Via Subcutaneous vs. Intravenous Route. The AAPS journal 26 (3) (2024)
Jacob Felderman, Lila Ramaiah, Maria-Dolores Vazquez-Abad, Dean Messing, Ying Chen
Anti-Drug Antibody Incidence Comparison of Therapeutic Proteins Administered Via Subcutaneous vs. Intravenous Route. The AAPS journal 26 (3) (2024)
Cynthia M Rohde, Claudia Lindemann, Michael Giovanelli, Rani S Sellers, Jan Diekmann, Shambhunath Choudhary, Lila Ramaiah, Annette B Vogel, Yana Chervona, Alexander Muik, Ugur Sahin
Toxicological Assessments of a Pandemic COVID-19 Vaccine-Demonstrating the Suitability of a Platform Approach for mRNA Vaccines. Vaccines 11 (2) (2023)
Cynthia M Rohde, Claudia Lindemann, Michael Giovanelli, Rani S Sellers, Jan Diekmann, Shambhunath Choudhary, Lila Ramaiah, Annette B Vogel, Yana Chervona, Alexander Muik, Ugur Sahin
Toxicological Assessments of a Pandemic COVID-19 Vaccine-Demonstrating the Suitability of a Platform Approach for mRNA Vaccines. Vaccines 11 (2) (2023)